The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial

NCT07114640 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Urinary Bladder, Overactive

Interventions

DRUG: Mirabegron 25mg
DRUG: Solifenacin 5 mg
DRUG: Tolterodine 4 mg
DRUG: Oxybutynin ER 5 mg

Sponsor

Far Eastern Memorial Hospital